RVPH

RVPH

Reviva Pharmaceuticals Holdings, Inc.

0.35 USD

Last updated Sep 5, 11:27 UTC

Yesterday HIGH

$0.56

Yesterday LOW

$0.51

52w HIGH

$17.2

52w LOW

$0.26

EPS

-0.19

PE

-1.86

Next Earnings

Nov 12, 2026

Overview News Government Trades Fundamentals

Reviva Pharmaceuticals Holdings, Inc. stock is down -26.46% since 30 days ago. The next earnings date is Nov 12, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 September’s closed higher than August.

Benzinga Insights

Wed May 13, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Newsdesk

Wed May 13, 2026

Reviva Pharmaceuticals Holdings shares are trading lower after the company announced it will be delisted from the Nasdaq.
Avi Kapoor

Wed May 13, 2026

Dow Falls 200 Points; US Producer Prices Surge In April

US stocks mixed as Dow drops over 200 points on opening. Nasdaq up 0.13%, S&P 500 down 0.13%. Tech sector up 0.4%, utilities down 1.7%. PPI rose 1.4% in April.
Benzinga Newsdesk

Wed May 13, 2026

Reviva Pharmaceuticals Holdings To Be Delisted From Nasdaq, Shares To Begin Trading On OTCQB On May 14, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.As previously disclosed, the common stock of Reviva Pharmaceuticals Holdings, Inc. (the "Company") was not in compliance
Benzinga Insights

Wed May 13, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sweta Killa

Wed May 6, 2026

Robert F. Kennedy Jr. Wants To Take 'Clear And Decisive Action' On Psychiatric Drugs Amid 'Deprescribing' Push: Big Pharma Should Pay Attention

Robert F. Kennedy Jr. unveiled a federal initiative to curb the overuse of psychiatric medications, emphasizing deprescribing and a shift toward preventive, patient-centered mental health care.
Caroline Ryan

Fri Apr 17, 2026

Deal Dispatch: Amazon Buys Globalstar, Instacart Grabs Instaleap, QVC Announces Bankruptcy

Major M&A deals include: Amazon's $11.6 billion acquisition of Globalstar, OpenAI buys Hiro Finance, and AIP acquires Avanos Medical.
Benzinga Newsdesk

Wed Apr 15, 2026

Reviva Pharmaceuticals Holdings Says Aims To Extend Brilaroxazine Patent Life And Exclusivity Potentially Through 2046; To Initiate Trial Activities In Q2 2026, Begin Enrollment In Q3 2026, For RECOVER-2; Preparing To Seek FDA Alignment On New Form Of Brilaroxazine For NDA

Regulation FD Disclosure.On April 15, 2026, Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") issued a letter to shareholders announcing certain business updates, including in connection with the
Benzinga Newsdesk

Wed Apr 8, 2026

Maxim Group Downgrades Reviva Pharmaceuticals to Hold

Maxim Group analyst Jason McCarthy downgrades Reviva Pharmaceuticals (NASDAQ:RVPH) from Buy to Hold.
Benzinga Newsdesk

Wed Apr 1, 2026

Watching Reviva Pharmaceuticals; Zacks Small-Cap Research Gives Stock $7 Price Valuation

IBIT IBIT $45.24 USD

ALOY ALOY $10.10 USD

VKTX $34.86 USD

UVXY $17.35 USD

BRUN BRUN $17.34 USD

CIFR $17.75 USD

AXSM $206.56 USD

FSLR $204.53 USD